Literature DB >> 9048641

Suprachiasmatic efferents avoid phenestrated capillaries but innervate neuroendocrine cells, including those producing dopamine.

T L Horvath1.   

Abstract

The key role of the suprachiasmatic nucleus in the diurnal regulation of anterior pituitary hormone secretions, including PRL, is well established. However, the pathway via suprachiasmatic signals reach the pituitary is ill defined. To determine whether suprachiasmatic efferents innervate neuroendocrine cells, the anterograde tracer, Phaseolus vulgaris leukoagglutinin, was injected iontophoretically into the suprachiasmatic nucleus in parallel with ip administration of fluorogold (20 mg/BW in saline). After visualization of anterogradely labeled processes with a dark blue chromogen. Vibratome sections were immunostained for fluorogold. As fluorogold labeling resulted in dense immunopositive granules without diffuse cytoplasmic labeling, selected sections were further immunostained for cytoplasmic tyrosine hydroxylase (dopamine). Anterogradely labeled suprachiasmatic efferents were observed in the medial preoptic area, periventricular regions, and the lateral aspects of the arcuate and ventromedial nuclei of the hypothalamus, whereas the median eminence and organum vasculosum laminae terminalis lacked labeled suprachiasmatic projections. All of the aforementioned regions contained a high number of cells immunoreactive for fluorogold. However, immunolabeling for fluorogold revealed no retrogradely labeled (ergo neuroendocrine) cells in the suprachiasmatic nucleus. Retrogradely labeled cells in all of these hypothalamic sites, with the exception of the median eminence and organum vasculosum laminae terminalis, were targets of suprachiasmatic nucleus axon terminals. In the preoptic area, anterior hypothalamus, periventricular area, and arcuate nucleus, subpopulations of dopamine cells were retrogradely labeled. In all of these areas, both retrogradely labeled and nonlabeled dopamine cells were frequently found to be in contact with dark blue, anterogradely labeled suprachiasmatic efferents. Electron microscopic examination confirmed the putative connections to be synaptic. This experiment provided evidence that the circadian pacemaker suprachiasmatic nucleus sends efferents onto neuroendocrine cells, but has no contacts with fenestrated capillaries. It was found that a population of median eminence-projective cells targeted by suprachiasmatic axons in the hypothalamus contains dopamine. These observations indicate no direct effect of the circadian pacemaker on the anterior hypophysis, but offer an indirect pathway via circadian signals, mediated by hypothalamic neural systems, that may regulate pituitary hormone secretion, in particular PRL.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9048641     DOI: 10.1210/endo.138.3.4976

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  16 in total

1.  Ghrelin-immunopositive hypothalamic neurons tie the circadian clock and visual system to the lateral hypothalamic arousal center.

Authors:  Tamas L Horvath; Alfonso Abizaid; Marcelo O Dietrich; Ying Li; Joseph S Takahashi; Joseph Bass
Journal:  Mol Metab       Date:  2012-08-18       Impact factor: 7.422

Review 2.  The regulation of neuroendocrine function: Timing is everything.

Authors:  Lance J Kriegsfeld; Rae Silver
Journal:  Horm Behav       Date:  2006-02-21       Impact factor: 3.587

3.  An alternate pathway for visual signal integration into the hypothalamo-pituitary axis: retinorecipient intergeniculate neurons project to various regions of the hypothalamus and innervate neuroendocrine cells including those producing dopamine.

Authors:  T L Horvath
Journal:  J Neurosci       Date:  1998-02-15       Impact factor: 6.167

4.  Kisspeptin Neurons in the Arcuate Nucleus of the Hypothalamus Orchestrate Circadian Rhythms and Metabolism.

Authors:  Stephanie L Padilla; Jazmine G Perez; Miriam Ben-Hamo; Christopher W Johnson; Raymond E A Sanchez; Ivana L Bussi; Richard D Palmiter; Horacio O de la Iglesia
Journal:  Curr Biol       Date:  2019-02-07       Impact factor: 10.834

5.  Molecular interrogation of hypothalamic organization reveals distinct dopamine neuronal subtypes.

Authors:  Roman A Romanov; Amit Zeisel; Joanne Bakker; Fatima Girach; Arash Hellysaz; Raju Tomer; Alán Alpár; Jan Mulder; Frédéric Clotman; Erik Keimpema; Brian Hsueh; Ailey K Crow; Henrik Martens; Christian Schwindling; Daniela Calvigioni; Jaideep S Bains; Zoltán Máté; Gábor Szabó; Yuchio Yanagawa; Ming-Dong Zhang; Andre Rendeiro; Matthias Farlik; Mathias Uhlén; Peer Wulff; Christoph Bock; Christian Broberger; Karl Deisseroth; Tomas Hökfelt; Sten Linnarsson; Tamas L Horvath; Tibor Harkany
Journal:  Nat Neurosci       Date:  2016-12-19       Impact factor: 24.884

Review 6.  Circadian rhythms have broad implications for understanding brain and behavior.

Authors:  Rae Silver; Lance J Kriegsfeld
Journal:  Eur J Neurosci       Date:  2014-05-05       Impact factor: 3.386

7.  Brain uncoupling protein 2: uncoupled neuronal mitochondria predict thermal synapses in homeostatic centers.

Authors:  T L Horvath; C H Warden; M Hajos; A Lombardi; F Goglia; S Diano
Journal:  J Neurosci       Date:  1999-12-01       Impact factor: 6.167

8.  Circadian control of kisspeptin and a gated GnRH response mediate the preovulatory luteinizing hormone surge.

Authors:  Wilbur P Williams; Stephan G Jarjisian; Jens D Mikkelsen; Lance J Kriegsfeld
Journal:  Endocrinology       Date:  2010-12-29       Impact factor: 4.736

9.  Central clock regulates the cervically stimulated prolactin surges by modulation of dopamine and vasoactive intestinal polypeptide release in ovariectomized rats.

Authors:  Maristela O Poletini; Jessica E Kennett; De'nise T McKee; Marc E Freeman
Journal:  Neuroendocrinology       Date:  2009-10-29       Impact factor: 4.914

10.  Synaptic interaction between hypocretin (orexin) and neuropeptide Y cells in the rodent and primate hypothalamus: a novel circuit implicated in metabolic and endocrine regulations.

Authors:  T L Horvath; S Diano; A N van den Pol
Journal:  J Neurosci       Date:  1999-02-01       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.